Imports from China at risk, but some firms may benefit, says CLSA

Dixon Technologies, Havells India, Voltas and Cipla are some of the Indian companies that could face issues over the next few months

At a time when the global economy and financial markets are grappling with the spreading coronavirus, analysts believe India could stand to benefit over the longer term as companies look at setting up alternative manufacturing base than China. In the short-term, however, there could be some supply-chain disruptions.

In their latest report, analysts at CLSA have pegged the total Indian imports from China in financial year 2018-19 (FY19) at $70.4 billion. A deep-dive in this import basket from China suggests Indian pharma, chemicals and electronic companies could see a disruption in supply chain in case of a prolonged issue with